Skip to main content
. 2004 Nov 30;92(1):36–40. doi: 10.1038/sj.bjc.6602263

Table 1. Pretreatment patient characteristics.

  Patient characteristics
Number of patients 37
Median age (range) 71.4 years (57.6–83.9)
   
Disease extent  
 Localised 1
 Bone mets only 13
 Bone+nodal disease 16
 Bone+liver/lung 7
   
Performance score  
 0 2
 1 18
 2 11
 3 5
 Missing 1
   
Symptomatic  
 No 3
 Yes 33
 Missing 1
   
Primary therapy  
 GnRH 18
 MAB 13
 Orchidectomy 3
 Antiandrogen monotherapy 3
   
PSA levels at start CL56  
 Median and (range) 183.5 (11.3–1560)
   
Alkaline phosphatase at start of CL56  
 ⩽120 18
 >120 19
   
Gleason score  
 8–10 6
 5–7 17
 ⩽4 3
 Missing 11
   
PSA normalised with prior androgen deprivation  
 No 16
 Yes 15
 Missing 6
   
Median time to androgen independence (AI) 25 months (range 4.4–136.7)
 Number AI<2 years 17
 Number AI>2 years 20
   
Median time AI to start study 14.3 months (range 1.8–46.2)
Number AI to start study<1 year 17
Number AI to start study >1 year 20